IP Library Granted Patent US 7,943,754
Granted Patent B2
US 7,943,754 · App. 10/709,691 · Granted May 17, 2011

Bioinformatically detectable group of novel regulatory bacterial and bacterial associated oligonucleotides and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,943,754
App. No.
10/709,691
Granted
May 17, 2011
Kind
B2
Abstract

The present invention relates to a first group of novel bacterial and human associated oligonucleotides, here identified as “Genomic Address Messenger” or “GAM” oligonucleotide, and a second group of novel operon-like bacterial and human polynucleotides, here identified as “Genomic Record” or “GR” polynucleotide. GAM oligonucleotides selectively inhibit translation of known “target” genes, many of which are known to be involved in various bacterial infections. Nucleic acid molecules are provided respectively encoding 21,916 bacterial and 6,100 human GAM precursor oligonucleotides, and 6,056 bacterial and 430 human GR polynucleotides, as are vectors and probes both comprising the nucleic acid molecules, and methods and systems for detecting GAM oligonucleotides and GR polynucleotides and specific functions and utilities thereof, for detecting expression of GAM oligonucleotides and GR polynucleotides, and for selectively enhancing and selectively inhibiting translation of the respective target genes thereof.

Claims (15)

1. An isolated nucleic acid, wherein the sequence of the nucleic acid is selected from the group consisting of:

(a) a sequence consisting of SEQ ID NO: 348;

(b) a sequence consisting of nucleotides 14-34 of SEQ ID NO: 4233864;

(c) a sequence consisting of nucleotides 14-36 of SEQ ID NO: 4233864;

(d) a sequence consisting of nucleotides 14-37 of SEQ ID NO: 4233864;

(e) a DNA encoding the nucleic acid of any one of (a)-(d), wherein the DNA is identical in length to (a)-(d), respectively; and

(f) the complement of any one of (a)-(e), wherein the complement is identical in length to (a)-(e), respectively.

2. An isolated nucleic acid, wherein the sequence of the nucleic acid is selected from the group consisting of:

(a) SEQ ID NO: 4233864;

(b) a DNA encoding the nucleic acid of (a), wherein the DNA is identical in length to (a); and

(c) the complement of (a) or (b), wherein the complement is identical in length to (a) or (b).

3. A vector comprising a human insert, wherein the human insert consists of the sequence of the nucleic acid of claim 1 , and wherein the vector comprises no other inserts but the nucleic acid of claim 1 .

4. A vector comprising a human insert, wherein the human insert consists of the sequence of the nucleic acid of claim 2 , and wherein the vector comprises no other inserts but the nucleic acid of claim 2 .

5. A probe consisting of a human insert, wherein the human insert consists of the sequence of the nucleic acid of claim 1 .

6. A probe consisting of a human insert, wherein the human insert consists of the sequence of the nucleic acid of claim 2 .

Assignments (2)
SECURITY INTEREST Recorded Dec 15, 2017
From: ROSETTA GENOMICS INC.; ROSETTA GENOMICS LTD; MINUET DIAGNOSTICS, INC.; CYNOGEN INC.
To: GENOPTIX, INC.
Reel/Frame 044899/0237 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2004
From: BENTWICH, ITZHAK; AVNIEL, AMIR
To: ROSETTA GEMONICS LTD
Reel/Frame 014647/0544 →